Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Airway Management Devices Market size was valued at USD 1.79 Billion in 2024 and is poised to grow from USD 1.89 Billion in 2025 to USD 2.9 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026–2033).

    Airway management device companies should focus on launching new products to stay competitive in the global market. Collaborations, acquisitions, and mergers are expected to be key strategies for leading airway management device providers looking to expand their market presence. Countries with developed healthcare infrastructure will spearhead the sales of airway management devices as per this airway management devices market analysis.  'Medtronic ', 'ICU Medical, Inc. ', 'Teleflex Incorporated ', 'Ambu A/S ', 'Convatec Group PLC ', 'Karl Storz SE & Co. KG ', 'Flexicare (Group) Limited ', 'Intersurgical Ltd. ', 'SunMed LLC ', 'Vyaire ', 'VBM Medizintechnik GmbH ', 'Verathon Inc. ', 'SourceMark ', 'Mercury Enterprises ', 'Atos Medical ', 'P3 Medical ', 'Henan Tuoren Medical Device Co., Ltd. ', 'Mederen Neotech Ltd. ', 'Bomimed ', 'Medis Medical (UK) Ltd. ', 'Olympus Corporation ', 'Armstrong Medical Ltd. (Eakin Healthcare Group) ', 'Nihon Kohden Corporation ', 'Shenzhen Hugemed Medical Technical Development Co., Ltd. ', 'Venner Medical Medizintechnik'

    Increasing air pollution and growing number of smokers around the world have contributed to a high incidence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. Airway management devices play a crucial role in the treatment of these disorders thereby their high occurrence will drive market growth in the future.  

    Use in Home Care Settings: Airway management device manufacturers should focus on the development of products that are suitable for home care use. Portable CPAP (continuous positive airway pressure) machines and nebulizers that can be used in home care environments will be high in demand for preference for home care among elderly increases rapidly in most parts of the world.  

    North America is forecasted to secure the top spot in the global airway management devices market forecast. Rising prevalence of chronic respiratory disorders, availability of favorable reimbursement policies, and high volume of surgeries performed in this region are helping it maintain its dominant stance on a global level. Canada and the United States are forecasted to emerge as the most opportune markets for airway management device suppliers operating in this region. High investments in R&D of advanced airway management devices and quick adoption of these novel technologies will also help North America remain the most opportune market for all airway management device providers through 2031 and beyond.  

    Feedback From Our Clients

    Global Airway Management Devices Market

    Report ID: SQMIG35B2165

    $5,300
    BUY NOW